Fibronostics to Exhibit at THASL 2025 Annual Conference in Bangkok
Fibronostics is pleased to announce its participation in the THASL 2025 Annual Conference, hosted by the Thai Association for the Study of the […]
Your blog category
Fibronostics is pleased to announce its participation in the THASL 2025 Annual Conference, hosted by the Thai Association for the Study of the […]
When it comes to liver disease, early intervention isn’t just helpful, it’s critical. Known as the body’s “silent organ,” the
Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis, is primarily known for affecting the gastrointestinal tract. However,
High blood pressure doesn’t just strain your heart – it may quietly damage your liver too. Several studies, including a
Liver disease often progresses silently, with early stages showing minimal or no symptoms. However, the encouraging news is that these
Liver steatosis commonly known as fatty liver is no longer a silent bystander in liver health. It’s the central feature
When people think about liver disease, the conversation usually centers around fibrosis – the amount of permanent scarring in the
Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are conditions tied to the buildup of fat in
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where fat accumulates in the liver, mainly due to issues with
Did you know that metabolic health plays a key role in liver function? With the rise in conditions like obesity,